CAR-T cells commonly express receptors RANTES receptors, such as CCR1, CCR3, and CCR5, and combined use of CCL5-expressing oncolytic virus with engineered CAR T cells powerfully promoted the viability and tumor clearance in some of the preclinical studies [118, 120]. Here, CCR1 is linked to neoplasm.